ÂÜÀòÂÒÂ×

Thomas Machnig is a seasoned medical professional with extensive experience in clinical development and medical affairs across various therapeutic areas. Currently serving as Senior Director Early Clinical Development and TA Head Hemophilia & Immunology Clinical Sciences at BioMarin Pharmaceutical Inc. since July 2020, Thomas previously held the position of Vice President Clinical Development at Pharvaris B.V. and spent nearly a decade at CSL Behring as Director of Global Medical Affairs, focusing on immunology and neurology. Early career contributions include significant roles at Boehringer Ingelheim, Healthcare Business of Merck, and Eli Lilly, with a strong emphasis on clinical studies, regulatory filings, and publication in peer-reviewed journals. Thomas holds degrees in Medicine, Cardiology, Business Administration, and Internship from esteemed institutions, showcasing a robust academic foundation complementing a dynamic professional trajectory.